|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10858 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-RUNX1/AML1 |
| 克隆性 | |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human RUNX1 (150-190aa) |
中文名稱(chēng) 急性髓細(xì)胞1蛋白抗體規(guī)格
英文名稱(chēng) Anti-RUNX1/AML1
別 名 Acute myeloid leukemia 1; Acute myeloid leukemia 1 protein; alpha subunit core binding factor; AML 1; AML1 EVI 1; Aml1 oncogene; AMLCR 1; AMLCR1; CBFA 2; CBFA2; Core binding factor alpha 2 subunit; Core binding factor runt domain alpha subunit 2; EVI 1; EVI1; HGNC; Oncogene AML 1; PEA2 alpha; PEBP2 alpha B; PEBP2A2; PEBP2aB; Polyomavirus enhancer binding protein 2 alpha B subunit; Run1; Runt related transcription factor 1; RUNX 1; SL3 3 enhancer factor 1 alpha B subunit; SL3/AKV core binding factor alpha B subunit; RUNX1_HUMAN.
產(chǎn)品屬性：
急性髓細(xì)胞1蛋白抗體規(guī)格 濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Horse, Rabbit
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 心 細(xì)胞生物 細(xì)胞凋亡
蛋白分子量 predicted molecular weight: 50kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human RUNX1 (150-190aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
急性髓細(xì)胞1蛋白抗體規(guī)格 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 AML1/Runx1 binds DNA as a monomer and through the Runt domain. DNA binding is increased by heterodimerization with CBFB. Isoform AML1L can neither bind DNA nor heterodimerize and interferes with the transactivation activity of AML1/Runx1. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T cell receptor enhancers, LCK, IL3 and GMCSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. AML1/Runx1 is expressed in a wide variety of tissues and is expressed at the highest levels in thymus, bone marrow and peripheral blood. Defects in AML1/Runx1 are the cause of familial platelet disorder with associated myeloid malignancy, an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia。
Function : CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.
Subunit : Heterodimer with CBFB. RUNX1 binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Isoform AML-1L can neither bind DNA nor heterodimerize. Interacts with TLE1 and ALYREF/THOC4. Interacts with ELF1, ELF2 and SPI1. Interacts via its Runt domain with the ELF4 N-terminal region. Interaction with ELF2 isoform 2 (NERF-1a) may act to repress RUNX1-mediated transactivation. Interacts with KAT6A and KAT6B. Interacts with SUV39H1, leading to abrogation of transactivating and DNA-binding properties of RUNX1. Interacts with YAP1. Interacts with HIPK2 (By similarity). Interaction with CDK6 prevents myeloid differentiation, reducing its transcription transactivation activity.
Subcellular Location : Nucleus.
Tissue Specificity : Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.
Post-translational modifications : Phosphorylated in its C-terminus upon IL-6 treatment. Phosphorylation enhances interaction with KAT6A.
Methylated.
Phosphorylated in Ser-249 Thr-273 and Ser-276 by HIPK2 when associated with CBFB and DNA. This phosphorylation promotes subsequent EP300 phosphorylation.
DISEASE : Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.
Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.
Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.
Defects in RUNX1 are the cause of familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]. FPDMM is an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.
Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.
Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.
Similarity : Contains 1 Runt domain.
Database links : UniProtKB/Swiss-Prot: Q01196.3
實(shí)驗(yàn)流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
急性髓細(xì)胞1蛋白抗體規(guī)格 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
技術(shù)外包服務(wù):
★急性髓細(xì)胞1蛋白抗體規(guī)格 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
正在熱銷(xiāo)的相關(guān)產(chǎn)品：
CK17(Human cytokeratin 17) ELISA Kit 人細(xì)胞角蛋白17Multi-class antibodies規(guī)格： 48T
Anti-HCG Beta 人絨毛膜激素β亞基單抗Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh Mitochondrial Pyruvate dehydrogenase kinase 1 酸脫氫酶激酶1抗體 規(guī)格 0.1ml
sPLA2(Human secreted phospholipase A2) ELISA Kit 人分泌型磷脂酶A2 96T
RANKL 英文名稱(chēng)： 骨保護(hù)蛋白配體抗體(破骨細(xì)胞分化因子) 0.1ml
CHD1 英文名稱(chēng)： ATP依賴的解旋酶CHD1抗體 0.1ml
Anti-HCG Beta 人絨毛膜激素β亞基單抗Multi-class antibodies規(guī)格： 0.1ml
Anti-Histone H1 (phospho Thr146) /FITC 熒光素標(biāo)記磷酸化組蛋白H1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-phospho APP(pThr668)/FITC 熒光素標(biāo)記抗磷酸化APP淀粉樣肽前體蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh ATP7B 銅轉(zhuǎn)運(yùn)蛋白質(zhì)β鏈抗體 規(guī)格 0.1ml
MBP (Myelin Basic Protein, Rat)peptide 髓鞘堿性蛋白(多肽)大鼠 0.5mg
G gamma12 英文名稱(chēng)： G蛋白偶聯(lián)受體γ12抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-mouse IgM/PE-Cy7 PE-Cy7標(biāo)記的兔抗小鼠IgM 規(guī)格 0.1ml
Anti-phospho APP(pThr668)/FITC 熒光素標(biāo)記抗磷酸化APP淀粉樣肽前體蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
MCP-4/CCL13(Human monocyte chemotactic protein 4) ELISA kit 人單核細(xì)胞趨化蛋白4Multi-class antibodies規(guī)格： 48T
Anti-FSH 促卵泡刺激素抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Mouse Anti-human IgM/Alexa Fluor 647 Alexa Fluor 647標(biāo)記的小鼠抗人IgM 規(guī)格 0.1ml
fMet(Human formylmine) ELISA Kit 人甲酰甲硫酸 96T
SLITRK4 英文名稱(chēng)： 神經(jīng)突觸相關(guān)蛋白SLITRK4抗體 0.2ml
Collagen II 英文名稱(chēng)： Ⅱ型膠原α1蛋白/軟骨鈣素抗體 0.1ml
Anti-FSH 促卵泡刺激素抗體Multi-class antibodies規(guī)格： 0.2ml
SoybeanCaseinDigestAgarMedium
ECC顯色培養(yǎng)基A 1000 mL/瓶 incubation media ECC顯色培養(yǎng)基A 1000 mL/瓶
血瓊脂培養(yǎng)基基礎(chǔ) 250g 加入脫纖維羊血或兔血，制成血瓊脂培養(yǎng)基，用于營(yíng)養(yǎng)要求較高的細(xì)菌的培養(yǎng)及溶血試驗(yàn)(GB 4789.10-...
瓊脂培養(yǎng)基KAgarmediumK(Xylose,lysine,deoxycholateagar)用于沙門(mén)氏菌選擇性分離培養(yǎng)
M17肉湯 250g 用于牛奶和乳制品中乳酸菌檢測(cè)和分離培養(yǎng)
MycoplasmaBrothMedium
氯-蛋白胨緩沖液(pH7.0) 250(g) incubation media 氯-蛋白胨緩沖液(pH7.0) 250(g)
月桂基鹽胰蛋白胨肉湯(LST) 250g 用于多管發(fā)酵法測(cè)定大腸菌群和糞大腸菌GB 4789.3-2010，GB/T 4789.38-2008，GB/T 4789.39-200...
抗生素檢定培養(yǎng)基6號(hào)AntibioticAgarNO.6用于粘菌素等的效價(jià)測(cè)定
緩沖甘油-氯溶液 250g 用于檢測(cè)產(chǎn)氣莢膜梭菌時(shí)樣品的貯存
急性髓細(xì)胞1蛋白抗體規(guī)格 卵磷脂-吐溫80營(yíng)養(yǎng)瓊脂 規(guī)格： 250g 用途： 用于化妝品細(xì)菌總數(shù)測(cè)定。(化妝品衛(wèi)生規(guī)范微生物檢驗(yàn)方法2007版，SN/T 2098-2008)。
改良卵磷脂肉湯 規(guī)格： 250g 用途： 用于化妝品微生物檢測(cè)中樣品稀釋和增菌。(FDA BAM Chapter 23，ISO 21149：2006，ISO 22718：200...
腦心浸出液肉湯BHI 規(guī)格： 100g 用途： 廣泛用于霉菌、酵母、細(xì)菌的培養(yǎng)，包括營(yíng)養(yǎng)要求較高的微生物的培養(yǎng)，特別用于食品衛(wèi)生微生物檢驗(yàn)...
麥芽浸膏湯 規(guī)格： 250g 用途： 用于酵母和霉菌的培養(yǎng)，還用于酸性罐頭食品商業(yè)無(wú)菌檢驗(yàn)(GB/T4789.26-2003)。
|
|
|
|
|
